Substituted hexahydropyrrolo(1,2-a)-quinoline, hexahydro-1H-pyrido(1,2-a)-quinoline, hexahydrobenzo(3)indene and octahydrophenanthrene CNS agents
申请人:PFIZER INC.
公开号:EP0090516A1
公开(公告)日:1983-10-05
Tricyclic benzo fused compounds of the formula
and pharmaceutically acceptable cationic and acid addition salts thereof, wherein n is zero, 1 or 2, and t is 1 or 2; M is CH or N, R1 is H or certain acyl groups; Q is CO2R4, CORS, C(OR7)R5R6, CN, CONR9R10, CH2NR9R10, CH2NHCOR11, CH2NHSO2R12, 5-tetrazolyl or when n is 1, Q and OR1 together form a lactone or certain reduced derivatives thereof; and Z is certain alkyl, alkoxy, alkoxyalkyl, aralkyl, aralkoxy, aryloxyalkyl or aralkoxyalkyl groups, are valuable central nervous system active agents, methods for their use, pharmaceutical compositions containing them and certain intermediates therefor.
式中的三环苯并融合化合物
及其药学上可接受的阳离子盐和酸加成盐,其中 n 为零、1 或 2,t 为 1 或 2;M 为 CH 或 N,R1 为 H 或某些酰基;Q 为 CO2R4、CORS、C(OR7)R5R6、CN、CONR9R10、CH2NR9R10、CH2NHCOR11、CH2NHSO2R12、5-四唑基,或当 n 为 1 时,Q 和 OR1 共同形成内酯或其某些还原衍生物;和 Z 是某些烷基、烷氧基、烷氧基烷基、芳基、芳氧基烷基或芳氧基烷基,这些都是有价值的中枢神经系统活性剂、使用方法、含有它们的药物组合物及其某些中间体。